Fifth Third Bancorp
BIVV

Fifth Third Bancorp’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Fifth Third Bancorp’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,945
Closed -$105K – 2482
2017
Q4 		$105K Sell
1,945
-1,725
-47% -$94.4K ﹤0.01% 1037
2017
Q3 		$209K Sell
3,670
-2,014
-35% -$118K ﹤0.01% 870
2017
Q2 		$342K Sell
5,684
-4,932
-46% -$281K ﹤0.01% 779
2017
Q1 		$578K Buy
+10,616
New +$523K ﹤0.01% 653

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Fifth Third Bancorp's BIVV Position: Q1 2018 in Review

Fifth Third Bancorp sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 1,945 shares — an estimated $105K sold.

Fifth Third Bancorp first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $578K in Q1 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Fifth Third Bancorp reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Fifth Third Bancorp sold 1,945 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $105K.
  • Fifth Third Bancorp first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Fifth Third Bancorp's Bioverativ Inc. Common Stock position peaked at $578K in Q1 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Fifth Third Bancorp's 13F filing for Q1 2018, filed 15 May 2018.